A detailed history of Virginia Retirement Systems Et Al transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 28,100 shares of ITOS stock, worth $231,544. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,100
Previous 42,000 33.1%
Holding current value
$231,544
Previous $556,000 44.78%
% of portfolio
0.0%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

SELL
$10.95 - $14.6 $152,205 - $202,940
-13,900 Reduced 33.1%
28,100 $307,000
Q2 2023

Aug 22, 2023

BUY
$12.93 - $18.05 $27,153 - $37,905
2,100 Added 5.26%
42,000 $556,000
Q1 2023

Jul 11, 2023

SELL
$13.02 - $22.62 $53,382 - $92,742
-4,100 Reduced 9.32%
39,900 $543,000
Q4 2022

May 17, 2023

BUY
$17.77 - $21.6 $17,770 - $21,600
1,000 Added 2.33%
44,000 $859 Million
Q3 2022

May 16, 2023

BUY
$18.6 - $27.25 $799,800 - $1.17 Million
43,000 New
43,000 $819 Million

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $293M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.